Check out these key findings about Akebia Therapeutics Inc. (AKBA)

With 3.5 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.92 million shares. The 52-week range on AKBA shows that it touched its highest point at $1.84 and its lowest point at $0.49 during that stretch. It currently has a 1-year price target of $4.33. Beta for the stock currently stands at 0.78.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AKBA was up-trending over the past week, with a rise of 26.67%, but this was up by 1.79% over a month. Three-month performance surged to 71.00% while six-month performance rose 22.14%. The stock gained 86.91% in the past year, while it has gained 37.90% so far this year. A look at the trailing 12-month EPS for AKBA yields -0.33 with Next year EPS estimates of -0.27. For the next quarter, that number is -0.04. This implies an EPS growth rate of 39.71% for this year and 11.11% for next year.

Float and Shares Shorts:

At present, 184.14 million AKBA shares are outstanding with a float of 165.56 million shares on hand for trading. On Feb 15, 2024, short shares totaled 8.0 million, which was 4.25% higher than short shares on Jan 12, 2024. In addition to Mr. John P. Butler MBA as the firm’s CEO, President & Director, Mr. Michel Dahan serves as its Senior VP & COO.

Institutional Ownership:

Through their ownership of 29.21% of AKBA’s outstanding shares, institutional investors have minority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AKBA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, AKBA has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and AKBA currently yields $0.00. In the past year, AKBA’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, AKBA has a current buyback yield of $0.00. This was $0.00 for the TTM, and it was $– for the past five years.

Summary of Insider Activity:

Insiders traded AKBA stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 12 while that of sell transactions has risen to 4 over the past year. The total number of shares bought during that period was 1,280,000 while 285,798 shares were sold.